Posatex is for the treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular Malassezia pachydermatis.
Product Information for Veterinary Healthcare Professionals
Posatex contains 8.5 mg/ml orbifloxacin, 0.9 mg/ml mometasone furoate (as monohydrate) and 0.9 mg/ml posaconazole and is indicated for the treatment of otitis externa.
Responsible use of Antibiotics
One of the active ingredients in Posatex is an antibiotic (Orbifloxacin). When used correctly, antibiotics have an important role by maintaining health and welfare of animals. However, there are concerns that resistance or resistant bacteria could be transferred from animal to human health, and vice versa, and reduce the effectiveness of some antibiotic treatments. It is vital that antibiotics are used in the correct and appropriate manner to minimise this possibility.
MSD Animal Health supports the responsible use of antibiotics.
For more information please refer to Ireland’s National Action Plan for Antimicrobial Resistance on www.agriculture.gov.ie.
For uses, dosage, contra-indications and warnings please consult product leaflet. Further information is available on request. Use medicines responsibly.
Cartons containing bottles of 17.5 ml or 35.1 ml. Not all pack sizes may be marketed.
Summary of Product Characteristics
For Summary of Product Characteristics click on this link.